Clinical trials
Completed Phase 1 Psychotic Disorders trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
73 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 3 |
| 2004 | 1 |
| 2005 | 4 |
| 2006 | 6 |
| 2007 | 2 |
| 2008 | 3 |
| 2009 | 6 |
| 2010 | 3 |
| 2011 | 5 |
| 2012 | 2 |
| 2013 | 5 |
| 2014 | 6 |
| 2015 | 8 |
| 2016 | 3 |
| 2017 | 1 |
| 2018 | 2 |
| 2020 | 2 |
| 2021 | 4 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 73 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Yale University | 11 |
| Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 7 |
| Luye Pharma Group Ltd. | 6 |
| Dartmouth-Hitchcock Medical Center | 3 |
| Amgen | 2 |
| King's College London | 2 |
| Mclean Hospital | 2 |
| New York State Psychiatric Institute | 2 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 |
| Pakistan Institute of Living and Learning | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Psychotic Disorders | 73 |
| Schizophrenia | 57 |
| Marijuana Abuse | 8 |
| Mood Disorders | 7 |
| Bipolar Disorder | 6 |
| Schizophrenia Spectrum and Other Psychotic Disorders | 5 |
| Mental Disorders | 3 |
| Depressive Disorder | 2 |
| Major Depressive Disorder | 2 |
| Substance-Related Disorders | 2 |
Trials
Showing 1 to 25 of 73. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.